Company Analysis

Ensysce Biosciences, Inc. (ENSC)

Nasdaq: ENSC · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2017
Grade3.8
◀ Past 1.8● Present 3.5▶ Future 5.2
2 est.

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Report filedMar 30, 2026Mar 10, 2025Mar 15, 2024Mar 30, 2023Mar 31, 2022Mar 15, 2021Mar 10, 2020Mar 11, 2019Mar 9, 2018
Revenue5,066,6505,210,0312,230,5202,523,3833,531,1993,931,209···
For lenders
Provision for credit losses··-150-3-1,8081,962···
Research and development10,376,8957,219,4377,587,47319,835,8754,690,0824,389,579···
Selling, general and administrative····18,711,5481,154,917···
General and administrative4,930,7014,720,7285,361,2346,909,60318,711,548····
Total operating expenses15,307,59611,940,16512,948,70726,745,47823,401,6305,544,496r3,328,6741,559,245·
Operating income-10,240,946-6,730,134-10,718,187-24,222,095-19,870,431-1,613,287r-3,328,674-959,240·
Interest expense6,3758,84814,7169,9091,197,826995,496···
Interest and investment income·····719,6464,249,8283,626,792·
Other income (expense), net73,43017,27715,42086,223-282,279r····
Total non-operating income (expense)64,759-1,256,87591,91214,410-9,275,4701,452,412···
Income before income taxes·····4,555,262r-512,096r2,675,949·
Income tax expense·····244,493555,200553,916·
Net income including non-controlling interests-10,176,187-7,987,009-10,626,275-24,207,685-29,145,901-160,875r-1,067,296r2,053,783·
Net income to non-controlling interests-487-74-13,201-35,393-62,190-217,645···
Net income·····4,310,769r-1,067,296r2,122,033·
Net income to common shareholders-10,175,700-7,987,225-10,626,011-25,085,496-29,886,85156,770-2,873,869-1,342,689·
Earnings per share, basic-3.98-11.45-70.40r-2,091.30rb-444.60rb0.00b···
Earnings per share, diluted-3.98-11.45-70.40r-2,091.30b-22.20b0.00···
Earnings per share, basic and diluted·····9.75rb-9.45rb-3.15rb·
Weighted average shares, basic2,557,377697,686150,937r11,995rb67,215rb1,051,248b···
Weighted average shares, diluted2,557,377697,686150,937r11,995b1,344,300b1,100,492b···
Weighted average shares, basic and diluted·····442,851rb441,420rb439,801rb·
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Provision for credit losses set aside for loans that may not be repaidus-gaap:ProvisionForLoanLeaseAndOtherLosses
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ENSC · research, not advice